Tripyridyl carboxamide orexin receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 213/24 (2006.01) A61K 31/44 (2006.01) A61P 3/04 (2006.01)

Patent

CA 2732682

The present invention is directed to tripyridyl carboxamide compounds which are antago-nists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are in-volved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. (Formula).

L'invention concerne des composés de tripyridyle carboxamide, qui sont des antagonistes de récepteurs d'orexine, et qui sont utiles pour le traitement ou la prévention de troubles neurologiques et psychiatriques, et de maladies dans lesquelles des récepteurs d'orexine sont impliqués. L'invention concerne également des compositions pharmaceutiques comprenant ces composés, et l'utilisation de ces composés et compositions dans la prévention ou le traitement de telles maladies dans lesquelles des récepteurs d'orexine sont impliqués (formule).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tripyridyl carboxamide orexin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tripyridyl carboxamide orexin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tripyridyl carboxamide orexin receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1442656

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.